Asia-Pacific Histocompatibility and Immunogenetics Association (APHIA) 2025 conference
- November 22, 2024
- admin@narisara
- 0
**TTCI Supports Speakers at APHIA 2025**
[Bangkok, Thailand] – 21 Nov 2024 – The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) is proud to support speakers at the Asia-Pacific Histocompatibility and Immunogenetics Association (APHIA) 2025 conference, held from February 5th to 7th, 2025.
TTCI is committed to advancing cancer immunotherapy in Thailand and the Asia-Pacific region. TTCI provides financial assistance to the speakers presenting on the sesssion “Celluluar Immunotherapy” at APHIA 2025:
“We are delighted to support these outstanding speakers at APHIA 2025, Their presentations will help advance the field of cancer immunotherapy.”
**About TTCI**
TTCI is a non-profit organization supporting the development of cancer immunotherapy in Thailand and the Asia-Pacific region. TTCI provides financial assistance to researchers and clinicians and organizes educational events.